Basics Cogent Biosciences, Inc. IPO Date: March 26, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.6B Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.24% Avg Daily Range (30 D): $0.21 | 2.42% Avg Daily Range (90 D): $0.22 | 3.53% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 3.48M Avg Daily Volume (90 D): 2M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 129 Avg Trade Size (Sh.) (90 D): 119 Institutional Trades Total Inst.Trades: 1,639 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $1.75M Avg Inst. Trade (90 D): $1.55M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.77M Avg Closing Trade (30 D): $3.4M Avg Closing Trade (90 D): $1.88M Avg Closing Volume: 190.18K     News Jul 9, 2025 @ 1:36 AM Cogent Biosciences Announces Pricing of Upsized Pu... Source: Christi Waarich Apr 15, 2025 @ 5:00 PM Gastrointestinal Stromal Tumor Market to Grow Rapi... Source: Delveinsight Jun 28, 2024 @ 1:18 PM Cogent (COGT) Up on SUMMIT Study Update Post Posit... Source: Zacks Equity Research Jun 14, 2024 @ 11:30 AM Cogent Biosciences Announces Additional Clinical D... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief C... Source: Cogent Biosciences, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.84 $-.52 $-.09 Diluted EPS $-1.84 $-.52 $-.09 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -269.5M $ -71.99M $ -67.93M Operating Income / Loss $ -288.47M $ -74.93M $ -73.73M Cost of Revenue $ $ $ Net Cash Flow $ -89.8M $ 27.84M $ 1.12M PE Ratio     Splits Nov 09, 2020:   1:4